18^th World Drug Delivery Summit

Regulatory Pathways and Compliance in Drug Delivery

Navigating the regulatory landscape is crucial for the development and approval of drug delivery systems. This session will provide insights into regulatory considerations, compliance, and ethical aspects.

Track A- FDA and EMA perspectives on drug delivery systems: Representatives from regulatory agencies will share their insights and perspectives on the evaluation and approval of drug delivery technologies, highlighting regulatory pathways and requirements.

Track B- Regulatory considerations for personalized medicine: Attendees will gain an understanding of the unique regulatory challenges and considerations associated with personalized drug delivery, including data protection and consent.

Track C- Data protection and patient consent in precision drug delivery: Ensuring patient data protection and informed consent are critical in personalized medicine. This subtopic will explore best practices and legal requirements.

Track D- Navigating the approval process for novel drug delivery technologies: This session will guide attendees through the complex process of gaining regulatory approval for innovative drug delivery systems, including clinical trial design and documentation.